FDA Inspection 1118882 — Biomat USA Inc

Biomat USA Inc — FEI 3023457

The FDA completed an inspection of Biomat USA Inc on January 30, 2020 in Salem, OR. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 30, 2020
Fiscal Year
2020
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Salem, OR (United States)